After-Hours Movers

NeurogesX (Nasdaq: NGSX) 25% LOWER; today announced that the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to the U.S. FDA did not recommend FDA approval of a new indication for Qutenza® (Capsaicin) 8% patch for the management of neuropathic pain (nerve pain) related to HIV associated peripheral neuropathy (HIV-PN).

Exide Technologies (NASDAQ: XIDE) 22% LOWER; reported Q3 EPS of $0.84, compared to $0.34 reported last year. Revenue for the quarter came in at $784.1 million versus the consensus estimate of $846.97 million.

True Religion Apparel, Inc. (NASDAQ: TRLG) 21.7% LOWER; reported Q4 EPS of $0.57, $0.14 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $119.4 million versus the consensus estimate of $128.9 million. Sees FY2012 EPS of $1.88-$1.95, versus the consensus of $2.37. Sees FY2012 revenue of $450-$460 million, versus the consensus of $494 million.

Sierra Wireless (NASDAQ: SWIR) ...